The effects of a diabetes pre-consultation booklet for patients with type 2 diabetes on patients’ and doctors’ communication during the consultation and on patient outcomes

Update Il y a 4 ans
Reference: ISRCTN12822620

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

Background and study aims It is important that patients are given the opportunity to be involved in their diabetes care. Good communication between the doctor and the patient can help patients be more involved. The aim of our study is to explore if a pre-consultation booklet for people with type 2 diabetes can help patients and diabetes hospital doctors communicate better in the consultation and improve patient outcomes. The pre-consultation intervention booklet will encourage people to ask questions and provide them with their own personal clinical data and examples of questions they might like to ask during the consultation. Who can participate? People with type 2 diabetes aged 75 or under who are attending general diabetes outpatient clinics at the Diabetes Day Centre at the University Hospital Galway for review appointments will be approached to participate in the study. What does the study involve? Participants will be randomly allocated to one of three groups. The first group will receive an intervention booklet (containing personalised clinical information and prompt questions) at least 48 hours before their review appointment. The second group will receive a general information booklet (containing a glossary of diabetes topics usually discussed during a review visit) at least 48 hours before their review appointment. The third group will not receive a booklet. Those participating in the study will need to attend the Diabetes Day Centre 1-4 weeks before their review clinic appointment to have their HbA1c, cholesterol, blood pressure and Body Mass Index measured. Participants will complete short questionnaires on a number of occasions including when they have their blood tests done at the beginning of the project, directly before and after their first and second review appointment, six weeks after their first and second appointment, and six months after their second review visit. Data from patients in the control, general information, and intervention groups will be compared to see if there are any differences in patient outcomes and in how patients and doctors communicate during the consultation. What are the possible benefits and risks of participating? Findings from our research study may help improve the way we deliver diabetes care in the future. Where is the study run from? The Diabetes Day Centre, University Hospitals Galway (Ireland). When is study starting and how long is it expected to run for? The study ran from January 2011 to January 2014. Who is funding the study? This project is funded by the Health Research Board (HRB) (Ireland). Who is the main contact? Dr Máire O Donnell [email protected]


Inclusion criteria

  • Type 2 Diabetes

Links